Finding A Rock ‘n Roll Moment In Dementia Diagnostics

Computational Scientists Merge Neurology And AI Into Dementia Diagnostic Tool Whose Promise Rose Sharply On Alzheimer’s Drug Approval In The US

Find a problem and develop the solution for it: so goes the accepted wisdom for successful health care technology adoption. But as Cognetivity Neurosciences CEO Sina Habibi demonstrates, the reverse can also provide a very valid business pathway.

alamy

Cognitive Neurosciences has experienced much forward momentum since In Vivo last spoke to the Vancouver, Canada company about its innovative, culture- and language-agnostic cognitive assessment tool.

Driving improvements in early-stage diagnosis is the chief aim of technologies being developed for use in the dementia market, but two years ago, Cognetivity Neurosciences was finding it hard to...

Co-founder and CEO of the company Sina Habibi, one of In Vivo’s 2021 Rising Leaders, then took the innovative step of advertising the test protocol to interested UK NHS trusts....

More from Leadership

More from In Vivo